Customer group: Guest | You do not have the permission to see the prices, please create an account.
Welcome back!

Palivizumab

Synagis®

   
Filter options: Filter reset
Order number
Concentration
Price
08000212
100 mg/ml
Note: For full product details, please login.
08000212
100 mg/ml
Note: For full product details, please login.
08000212
100 mg/ml
Note: For full product details, please login.
08000212
100 mg/ml
Note: For full product details, please login.
08000212
100 mg/ml
Note: For full product details, please login.

Drug name: Synagis®

INN: Palivizumab

API type: Palivizumab is a recombinant humanised monoclonal antibody produced by DNA technology in mouse myeloma host cells.

Pharmacotherapeutic group: Immune sera immunoglobulins, specific immunoglobulins

ATC code: J06BB16

General function:

Short description:

Original license holder:

Marketing authorisation numbers: EU/1/99/117/001 - 004

Marketing authorisation holder: AbbVie Ltd; Maidenhead; SL6 4UB; United Kingdom

Name of the manufacturer of the biological active substance: Boehringer Ingelheim Pharma GmbH & Co. KG; D-88397 Biberach an der Riss; Germany

Name and address of the manufacturer responsible for batch release: AbbVie S .r.l. 04011; Campoverde di Aprilia(Latina); Italy

Max shelf life: 48 months

Storage conditions: 2°C – 8°C

List of excipients: Powder: Histidine, Glycine, Mannitol (E421)
Solvent: Water for injections